Učitavanje...
Extending the lymphoblastoid cell line model for drug combination pharmacogenomics
Combination drug therapies have become an integral part of precision oncology, and while evidence of clinical effectiveness continues to grow, the underlying mechanisms supporting synergy are poorly understood. Immortalized human lymphoblastoid cell lines (LCLs) have been proven as a particularly us...
Spremljeno u:
| Izdano u: | Pharmacogenomics |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212852/ https://ncbi.nlm.nih.gov/pubmed/34044623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0160 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|